Cargando…

Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells

The human lung cell A549 is susceptible to infection with a number of respiratory viruses. However, A549 cells are resistant to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in conventional submerged culture, and this would appear to be due to low expression levels of the SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Michihito, Kishimoto, Mai, Itakura, Yukari, Tabata, Koshiro, Intaruck, Kittiya, Uemura, Kentaro, Toba, Shinsuke, Sanaki, Takao, Sato, Akihiko, Hall, William W., Orba, Yasuko, Sawa, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423671/
https://www.ncbi.nlm.nih.gov/pubmed/34517212
http://dx.doi.org/10.1016/j.bbrc.2021.09.015
_version_ 1783749514417405952
author Sasaki, Michihito
Kishimoto, Mai
Itakura, Yukari
Tabata, Koshiro
Intaruck, Kittiya
Uemura, Kentaro
Toba, Shinsuke
Sanaki, Takao
Sato, Akihiko
Hall, William W.
Orba, Yasuko
Sawa, Hirofumi
author_facet Sasaki, Michihito
Kishimoto, Mai
Itakura, Yukari
Tabata, Koshiro
Intaruck, Kittiya
Uemura, Kentaro
Toba, Shinsuke
Sanaki, Takao
Sato, Akihiko
Hall, William W.
Orba, Yasuko
Sawa, Hirofumi
author_sort Sasaki, Michihito
collection PubMed
description The human lung cell A549 is susceptible to infection with a number of respiratory viruses. However, A549 cells are resistant to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in conventional submerged culture, and this would appear to be due to low expression levels of the SARS-CoV-2 entry receptor: angiotensin-converting enzyme-2 (ACE2). Here, we examined SARS-CoV-2 susceptibility to A549 cells after adaptation to air-liquid interface (ALI) culture. A549 cells in ALI culture yielded a layer of mucus on their apical surface, exhibited decreased expression levels of the proliferation marker KI-67 and intriguingly became susceptible to SARS-CoV-2 infection. We found that A549 cells increased the endogenous expression levels of ACE2 and TMPRSS2 following adaptation to ALI culture conditions. Camostat, a TMPRSS2 inhibitor, reduced SARS-CoV-2 infection in ALI-cultured A549 cells. These findings indicate that ALI culture switches the phenotype of A549 cells from resistance to susceptibility to SARS-CoV-2 infection through upregulation of ACE2 and TMPRSS2.
format Online
Article
Text
id pubmed-8423671
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84236712021-09-08 Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells Sasaki, Michihito Kishimoto, Mai Itakura, Yukari Tabata, Koshiro Intaruck, Kittiya Uemura, Kentaro Toba, Shinsuke Sanaki, Takao Sato, Akihiko Hall, William W. Orba, Yasuko Sawa, Hirofumi Biochem Biophys Res Commun Article The human lung cell A549 is susceptible to infection with a number of respiratory viruses. However, A549 cells are resistant to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in conventional submerged culture, and this would appear to be due to low expression levels of the SARS-CoV-2 entry receptor: angiotensin-converting enzyme-2 (ACE2). Here, we examined SARS-CoV-2 susceptibility to A549 cells after adaptation to air-liquid interface (ALI) culture. A549 cells in ALI culture yielded a layer of mucus on their apical surface, exhibited decreased expression levels of the proliferation marker KI-67 and intriguingly became susceptible to SARS-CoV-2 infection. We found that A549 cells increased the endogenous expression levels of ACE2 and TMPRSS2 following adaptation to ALI culture conditions. Camostat, a TMPRSS2 inhibitor, reduced SARS-CoV-2 infection in ALI-cultured A549 cells. These findings indicate that ALI culture switches the phenotype of A549 cells from resistance to susceptibility to SARS-CoV-2 infection through upregulation of ACE2 and TMPRSS2. Elsevier Inc. 2021-11-05 2021-09-08 /pmc/articles/PMC8423671/ /pubmed/34517212 http://dx.doi.org/10.1016/j.bbrc.2021.09.015 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sasaki, Michihito
Kishimoto, Mai
Itakura, Yukari
Tabata, Koshiro
Intaruck, Kittiya
Uemura, Kentaro
Toba, Shinsuke
Sanaki, Takao
Sato, Akihiko
Hall, William W.
Orba, Yasuko
Sawa, Hirofumi
Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
title Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
title_full Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
title_fullStr Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
title_full_unstemmed Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
title_short Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
title_sort air-liquid interphase culture confers sars-cov-2 susceptibility to a549 alveolar epithelial cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423671/
https://www.ncbi.nlm.nih.gov/pubmed/34517212
http://dx.doi.org/10.1016/j.bbrc.2021.09.015
work_keys_str_mv AT sasakimichihito airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT kishimotomai airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT itakurayukari airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT tabatakoshiro airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT intaruckkittiya airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT uemurakentaro airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT tobashinsuke airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT sanakitakao airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT satoakihiko airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT hallwilliamw airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT orbayasuko airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells
AT sawahirofumi airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells